Passion for Precision



ITM’s subsidiary ITG Isotope Technologies Garching GmbH recently received Marketing Authorization for EndolucinBeta / (n.c.a.) Lutetium (177Lu) chloride…

View details >>

Precision Oncology

Targeted Radionuclide Therapy is a medical specialty using very small amounts of radioactive materials, called radiopharmaceuticals, to diagnose and treat various diseases, like cancer…

View details >>

August 04, 2016

ITM´s subsidiary ITG receives Drug Approval for EndolucinBeta®

Full releases >>

May 10, 2016

EMA/CHMP adopts positive opinion for ITM’s EndolucinBeta®

Full releases >>

March 24, 2016

ITM and Scil Proteins announce new Partnership for Targeted Radio Conjugates

Full releases >>

Find challenging opportunities within the ITM Group. Our employees are a key success factor, as each individual contributes to the overall success of the Company through his/her work ...

Join the ITM Team >>